Deep Brain Stimulation Systems Market Growth – at a CAGR of 8.1% During Forecast Period 2019-2027


Increasing investments in research and development activities, rising demand for minimally invasive procedures and rising public awareness in several developed and developing countries are expected to drive global market revenue growth

Emergen Research has published its latest report titled, “Deep Brain Stimulation (DBS) Systems Market Analysis, By Product (Dual-Channel & Single Channel), By Application (Parkinson's Disease, Pain Management, Obsessive-Compulsive Disorder (OCD), Epilepsy, Essential Tremor, Depression, Dystonia), By End Use, By Region, Forecasts To 2027”

According to Emergen Research, the global deep brain stimulation (DBS) systems market size was USD 1277.5 million in 2019 and is expected to reach USD 2122.8 million in 2027 and register a revenue CAGR of 8.1% during the forecast period, 2020-2027.

Market Dynamics:

Deep brain stimulation (DBS) is a neurological procedure that involves implantation of electrodes in brain that delivers electrical impulses to block abnormal activity causing symptoms. The DBS has three parts including neurostimulator, led, and an extension that coordinate electric pulses and help in reducing symptoms of tremors, stiffness, slowness, and walking problems caused by many neurological diseases. One of the key factors surging demand for deep brain stimulation systems is the increasing prevalence of lifestyle-associated diseases such as chronic pain and depression, neurological disorders such as Parkinson’s disease, Alzheimer’s disease, dystonia, multiple sclerosis, and epilepsy among others.

Click Here to Access Free sample PDF Copy of the Report@

Revenue growth of the global market is attributed to factors such as technological advancements in deep brain stimulating systems including rechargeable implantable pulse generators, robot-assisted implantation, and rising adoption of advanced DBS systems in many hospitals, ambulatory care services, and neurological centers. In addition, increasing geriatric population and rising focus on developing advanced products are expected to fuel market growth going ahead.  However, high cost of DBS devices, limited access to advanced treatment, and availability of other treatments such as surgeries and drug therapies, and high chances of side effects of DBS products are expected to hamper overall market growth during the forecast period.

COVID-19 Impact Analysis 

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants continue to cause concerns and impact normal routines

Epilepsy Segment to Register Highest Revenue Growth:

The epilepsy segment is expected to register highest revenue growth over the forecast period. This can be attributed to rising incidence of epilepsy across the globe, high usage of deep brain stimulation due to low therapeutic response to other treatments, and increasing awareness about availability of advanced treatments and products.   

Hospital Segment to Account for Largest Revenue Share:

The hospital segment is expected to account for largest revenue share over the forecast period owing to increasing prevalence of various neurological disorders, availability of advanced technological systems for complicated surgeries, improving healthcare infrastructure and treatment facilities.   

Looking for Discount [Click on the link] @

Asia Pacific to Register Rapid Revenue CAGR: 

Asia Pacific market revenue is expected to expand at a rapid CAGR during the forecast period owing to increasing prevalence of various chronic diseases such as Parkinson’s disease, OCD, epilepsy, and depression across the region, improving healthcare infrastructure and rising awareness about deep brain stimulation devices. In addition, increasing healthcare spending, increasing adoption of advanced treatment and devices, increasing number of hospitals and neurology centers across the region are expected to fuel Asia Pacific market growth during the forecast period. 

Major Companies in the Market Include:

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Boston Scientific Corporation
  • Functional Neuromodulation Ltd.
  • Beijing PINS Medical Co., Ltd.
  • Medtronic plc
  • NeuroPace Inc.
  • Nevro Corporation
  • Neuronetics Inc.

For the purpose of this report, Emergen Research has segmented Deep Brain Stimulations (DBS) systems on the basis of product, application, end use and region:

Product Outlook (Revenue, USD Million; 2017-2027)

  • Dual Channel
  • Single Channel

Application Outlook (Revenue, USD Million; 2017-2027)

  • Fluid Replacement
  • Parkinson's Disease
  • Pain Management
  • Obsessive-Compulsive Disorder (OCD)
  • Epilepsy
  • Essential Tremor
  • Depression
  • Dystonia
  • Others

End Use Outlook (Revenue, USD Million; 2017-2027)

  • Hospitals
  • Ambulatory Care Center
  • Neurology Center   
  • Others

Have a look at Report Description and Table of Contents of Market Report@

Regional Outlook (Revenue, USD Million; 2017-2027)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of MEA

Explore more reports offered by Emergen Research:

The global NGS sample preparation market is estimated to grow at a CAGR of 9.3% from USD 3.11 billion in 2019 to USD 6.63 billion in 2027. The anticipated next generation sequencing (NGS) sample preparation revenue growth can be attributed to the production of products which enable high quality libraries to be generated and the result to be successfully sequenced.

The global nucleic acid isolation and purification market size was valued at USD 2,370.0 Million in 2019 and is forecasted to reach USD 4,180.0 Million by 2027 at a CAGR of 6.9%. A large untapped class of biomolecules, which play a key role in disease growth, are present in several species of the RNA.

The global interoperability solutions in healthcare market is valued at USD 2.27 billion in 2019 and is forecasted to reach USD 5.29 billion by 2027 at a CAGR of 11.1% in terms of value. Growing acceptance by healthcare agencies of interoperability technologies, rising efforts to develop healthcare services, beneficial policy programs to enhance patient safety, strong budget support, and emphasis on patient-centered treatment are some of the key drivers that drive market development.

The global viral vector and plasmid manufacturing market size was valued at USD 358.4 million in 2019 and is anticipated to reach USD 1.12 Billion by 2027 at a CAGR of 14.3%. Advanced treatments, including gene therapy using multiple viral and non-viral vectors, have paved a way to treat many heritable and inherited diseases that previously lacked successful treatment modalities.

The global orthopedics devices market is forecasted to grow at a rate of 3.9% from USD 47.89 Billion in 2019 to USD 65.29 Billion in 2027. The demand is projected to be fueled by a high incidence of orthopedic disorders such as degenerative bone disorder combined with a rising elderly population and growing occurrences road accidents.

 About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Visit for More Insights:

Explore Our Custom Intelligence services | Growth Consulting Services

Read Our Press release@

Read Our Blog@






Back to news